Results 281 to 290 of about 549,282 (362)

Total neoadjuvant therapy for locally advanced rectal cancer. [PDF]

Cochrane Database Syst Rev
Mueller S, Kao YS, Kastner C, Chen PH, Hendricks A, Lee GY, Koehler F, Jhou HJ, Germer CT, Kang EY, Janka H, Ho CL, Lee CH, Wiegering A.   +13 more
europepmc   +1 more source

The Role of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: Enhancing Post‐Surgical Outcomes and Overcoming Relapse

Medicine Advances, EarlyView.
Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that's usually detected at an advanced stage and has a high recurrence rate despite surgical resection, making treatment challenging. Although mitotane is still the only approved treatment, its poor effectiveness has raised interest in immunotherapy with immune checkpoint inhibitors (ICIs ...
Jawairya Muhammad Hussain, Saim Mahmood Khan, Haiqa Sultan, Diya Rathi, Eyob Mekonnen Woldeyohannes, Zemichael Getu Alemayehu   +5 more
wiley   +1 more source

Psychosocial Challenges After Treatment for Colorectal and Anal Cancer: A Descriptive Study

Medicine Advances, EarlyView.
After treatment for colorectal and anal cancer a lot of patients experience psychological distress. This prospective single center observational study aimed to identify these psychosocial problems and examine if patients experiencing psychosocial issues could be correlated to age, gender, or tumor stadium.
Birthe Thing Oggesen, Jacob Rosenberg
wiley   +1 more source

Lateral pelvic lymph nodes dissection of rectal neuroendocrine neoplasms: A prospective case-series and literature review

Yueyang Zhang, Yi Yang, Gao Chang-yuan, Hong Zhao, Haitao Zhou   +4 more
openalex   +1 more source

Prospective clinical cohort study on the accuracy of magnetic resonance imaging in preoperative staging for cancer of the rectum with node-by-node analysis by pathologists. [PDF]

Rev Assoc Med Bras (1992)
Rudinská LI, Sengul I, Škarda J, Sengul D, Pelikán A, Koscielnik P, Ihnát P.   +6 more
europepmc   +1 more source

A butyrate‐producing synbiotic mitigates intestinal inflammation in a murine colitis model

mLife, EarlyView.
Abstract Inflammatory bowel disease (IBD) is a chronic condition characterized by intestinal inflammation and gut dysbiosis, with limited treatment options primarily focused on immune‐modulating therapies. Among potential therapeutic agents, butyrate has emerged as a promising candidate due to its anti‐inflammatory and gut‐restorative properties ...
Hyuna Sung, Soo Yoon Cho, Seong Hyeok Ma, Jin Sun You, Mi Young Yoon, Sang Sun Yoon   +5 more
wiley   +1 more source

The articulated laparoscopic total mesorectal excision for rectal cancer (ATOME trial): a single-arm, prospective trial with pre-specified comparison to robotic surgery. [PDF]

Trials
Kim KE, Bae SU, Lee SH, Lim DR, Ha HK, Kim J, Ryu HS, Park SY, Kang SI, Son GM, Lee SY, Kim CH, Lee KH, Ha GW, Kim HJ, Ji WB, Kim WR, Kang SH, Sung NS, Kim JH, Lee TG, Kim MJ, Jeong WK, Baek SK.   +23 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 15 No. 3 [PDF]

, 1981

core   +1 more source

Protective Properties of the White Button Mushroom, Agaricus bisporus, in a Mouse Model of Colitis

Molecular Nutrition &Food Research, EarlyView.
In this study, whole mushroom powder (WMP) from white button mushrooms was tested for gut health benefits. In vitro digested WMP (IVD‐WMP) could reduce the permeability of a gastrointestinal cell layer. In mouse studies, WMP was tested as a preventative and a treatment for dextran sulfate sodium (DSS) induced colitis. WMP could improve recovery, reduce
Elaine Dempsey, Aaron M. Walsh, Supriya Yadav, Jude Wilson, Frederick J. Sheedy, Sinead C. Corr   +5 more
wiley   +1 more source

Rectal Cancer Pain Score: A prospective cohort validation study across recovery stages. [PDF]

Colorectal Dis
Kuhlmann L, Emmertsen KJ, Krogsgaard M, Frederiksen NA, Lauritzen MB, Christensen P, Juul T, Drewes AM.   +7 more
europepmc   +1 more source